Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: F. Schettini, S. Nucera, F. Brasó-Maristany, I. De Santo, T. Pascual, M. Bergamino, P. Galván, B. Conte, E. Seguí, I. García Fructuoso, R. Gómez Bravo, P. Rivera, A.B. Rodríguez, O. Martínez-Sáez, S. Ganau, E. Sanfeliu, B. González-Farre, M.J. Vidal Losada, B. Adamo, I. Cebrecos, E. Mension, G. Oses, P. Jares, S. Vidal-Sicart, M. Mollà, M. Muñoz, A. Prat

Journal title: ESMO Open

Journal number: 9

Journal publisher: ESMO OPen

Published year: 2024

Published pages: 103619

DOI identifier: 10.1016/j.esmoop.2024.103619

ISSN: 2059-7029